Sandwalk Bioventures is a cutting-edge consultancy firm in the field of microbiome science and life sciences, offering tailored solutions to companies and investors. The company focuses on helping food and biopharma start-ups bring their products to market by providing support in corporate, regulatory, and commercial affairs. Additionally, it assists larger corporations and investment firms in making informed decisions through evidence-based market insights. Sandwalk is particularly dedicated to assisting non-EU companies in navigating EU regulations and marketing their products, while also supporting EU companies in their regulatory efforts in the US. The company's expertise is underlined by its team's profound understanding of the science and extensive industry experience, distinguishing it from traditional advisory services. The name "Sandwalk" derives from Charles Darwin's thinking path near Kent, UK, where he developed his theories and conducted experiments, reflecting the company's commitment to a systematic methodology based on a thorough assessment of the science for bringing disruptive innovations to life. Founded in 2019 and headquartered in Spain, Sandwalk Bioventures represents a valuable player in the field of biotechnology consultancy. With a focus on emerging technologies and an experienced team, the company is poised to make significant contributions to the burgeoning microbiome and life sciences industries.
There is no investment information
No recent news or press coverage available for Sandwalk BioVentures.